Biomarkers in immunotherapy: literature review and future directions

Within the past decade, immunotherapy has revolutionized the treatment of advanced non-small lung cancer (NSCLC). Immune checkpoint inhibitors (ICIs) such as pembrolizumab, nivolumab, atezolizumab, and durvalumab have shown superiority over chemotherapy regimens in patients with programmed death-lig...

Descripción completa

Detalles Bibliográficos
Autores principales: Pharaon, Rebecca, Koczywas, Maria A., Salgia, Sabrina, Mohanty, Atish, Massarelli, Erminia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Role of Precision Imaging in Thoracic Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578474/
https://www.ncbi.nlm.nih.gov/pubmed/33145089
http://dx.doi.org/10.21037/jtd.2020.04.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578474/
https://www.ncbi.nlm.nih.gov/pubmed/33145089
http://dx.doi.org/10.21037/jtd.2020.04.15

Ejemplares similares